These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 7106193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F, Postema F, Medema HM, Van den Berg CJ.
    Life Sci; 1981 Jul 27; 29(4):331-5. PubMed ID: 7278490
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F, Achilli G, Perego C, Algeri S.
    Neurosci Lett; 1981 Nov 18; 27(1):61-7. PubMed ID: 7329624
    [Abstract] [Full Text] [Related]

  • 11. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P.
    J Pharm Pharmacol; 1987 Feb 18; 39(2):127-9. PubMed ID: 2881997
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW, Slimovitch C, Toffano G.
    Br J Pharmacol; 1990 Apr 18; 99(4):741-9. PubMed ID: 2361171
    [Abstract] [Full Text] [Related]

  • 14. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ.
    Eur J Pharmacol; 1976 Sep 18; 39(1):33-40. PubMed ID: 964303
    [Abstract] [Full Text] [Related]

  • 15. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD, Keller RW, Zigmond MJ, Stricker EM.
    Brain Res; 1989 May 22; 487(2):215-24. PubMed ID: 2786443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain.
    Westerink BH, Korf J.
    Eur J Pharmacol; 1975 Aug 22; 33(1):31-40. PubMed ID: 126169
    [Abstract] [Full Text] [Related]

  • 18. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 22; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 19. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E, Friedman E.
    Eur J Pharmacol; 1981 Nov 19; 76(1):25-9. PubMed ID: 7318921
    [Abstract] [Full Text] [Related]

  • 20. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1987 Mar 19; 39(3):196-202. PubMed ID: 2883284
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.